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Dear Editor,
We appreciate the interest in our article investigating the 
association of vitamin D level with severity and outcome 
of COVID-19 [1]. Our primary goal was to evaluate the 
prognostic role of serum vitamin D concentration on the 
extent of lung involvement and final outcome in patients 
with COVID-19.
In patients with COVID-19 pneumonia, a hyperinflam-
matory syndrome with activation of the complements sys-
tem may be involved in progression of the disease to acute 
respiratory distress syndrome (ARDS). The C5a–C5aR 
axis plays an important role in progression of the disease to 
ARDS. Vitamin D binding protein (DBP) release augments 
the chemotactic effect of complement derived C5a and C5a 
des Arg, leading to a cascade of inflammatory responses [2]. 
25(OH)D3 and 1,25(OH)2D3 compete for the same bind-
ing site on DBP and so may inhibit this chemotaxis [3]. A 
recent study by Batur et al. [4] suggested that variations in 
the prevalence of COVID-19 and its mortality rates among 
countries may be explained by vitamin D metabolism dif-
fered by the DBP polymorphism of rs7041 and rs4588. 
Although our study did not investigate the role of DBP in 
COVID-19 severity, our results and those of other studies 
in other countries, such as Weir et al. in USA (5), confirmed 
the role of vitamin D level in COVID-19 severity and out-
comes. These studies provided new evidence for clinicians 
and health policy makers to consider vitamin D supplemen-
tation for the improvement of clinical outcome of patients 
with COVID-19. However, currently we need to expand our 
knowledge on the mechanism of the association of vitamin 
D and COVID-19 especially by studying the role of DBP. 
Hence, further studies in this field are highly recommended.
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